Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
复制标题
DOI:
10.1038/ng1939
复制
发表时间:
2007-01-01
期刊:
影响因子:
30.8
通讯作者:
Gelb, Bruce D.
中科院分区:
文献类型:
--
作者:
Tartaglia, Marco;Pennacchio, Len A.;Gelb, Bruce D.
Noonan syndrome is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart defects and skeletal anomalies(1). Increased RAS-mitogen-activated protein kinase (MAPK) signaling due to PTPN11 and KRAS mutations causes 50% of cases of Noonan syndrome(2-6). Here, we report that 22 of 129 individuals with Noonan syndrome without PTPN11 or KRAS mutation have missense mutations in SOS1, which encodes a RAS-specific guanine nucleotide exchange factor. SOS1 mutations cluster at codons encoding residues implicated in the maintenance of SOS1 in its autoinhibited form. In addition, ectopic expression of two Noonan syndrome-associated mutants induces enhanced RAS and ERK activation. The phenotype associated with SOS1 defects lies within the Noonan syndrome spectrum but is distinctive, with a high prevalence of ectodermal abnormalities but generally normal development and linear growth. Our findings implicate gain-of-function mutations in a RAS guanine nucleotide exchange factor in disease for the first time and define a new mechanism by which upregulation of the RAS pathway can profoundly change human development.